Stockscreener 앱 받기
1.63
1.24%
0.02
시간 외 거래:
1.63
전일 마감가:
$1.61
열려 있는:
$1.64
하루 거래량:
171.79K
Relative Volume:
0.34
시가총액:
$64.56M
수익:
$41.21M
순이익/손실:
$-15.12M
주가수익비율:
-4.529
EPS:
-0.3599
순현금흐름:
$-17.19M
1주 성능:
+1.24%
1개월 성능:
+15.60%
6개월 성능:
+143.28%
1년 성능:
+77.81%
1일 변동 폭
$1.61
$1.6999
1주일 범위
$1.49
$1.6999
52주 변동 폭
$0.605
$1.885
Myomo Inc Stock (MYO) Company Profile
명칭
Myomo Inc
전화
617-996-9058
주소
One Broadway, 14th Floor, Cambridge, MA
Compare MYO vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MYO
Myomo Inc
|
1.63 | 63.77M | 41.21M | -15.12M | -17.19M | -0.3599 |
ABT
Abbott Laboratories
|
97.50 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Myomo Inc Stock (MYO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-31 | 개시 | Craig Hallum | Buy |
| 2024-05-20 | 개시 | Lake Street | Buy |
| 2023-12-15 | 개시 | H.C. Wainwright | Buy |
| 2020-11-11 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2020-05-27 | 개시 | Dougherty & Company | Buy |
| 2017-10-02 | 개시 | H.C. Wainwright | Buy |
모두보기
Myomo Inc 주식(MYO)의 최신 뉴스
Discontinued operations of Myomo, Inc. – HAN:0M61 - TradingView
0M61 Forecast — Price Target — Prediction for 2027 - TradingView
Myomo raises FY26 sales guidance to $45-47 million range - scanx.trade
Myomo Q2FY26 Results: Revenue up 21%, guidance raised to $45-47 million - scanx.trade
Myomo Q2 2026 Earnings Call Transcript - Benzinga
Myomo Inc. (MYO) Q2 2026 Earnings: Wider-Than-Expected Loss Met With Modest Stock GainQuarterly Earnings Report - dars.gov.et
ETFs Investing in Myomo, Inc. Stocks - TradingView
Myomo Inc (MYO) Chief Medical Officer Harry Kovelman Sells 15,48 - GuruFocus
Myomo (NYSE: MYO) insider to sell 15,844 shares after two recent sales - Stock Titan
Director of Myomo (NYSE: MYO) moves to sell shares from recent stock awards - Stock Titan
Myomo Inc. (MYO) Slips 0.7% to $1.42 as Shares Consolidate Within Narrow Trading RangeFactor Valuation - vinanet.vn
MYO Q2 2026 Earnings: EPS Miss of 18.81% Sends Shares Down 4.9%Earnings Decline Risk - vinanet.vn
Myomo to Present at the H.C. Wainwright 28th Annual Global Investment Conference - BioSpace
A robotic arm device maker will present in New York Sept. 14-16 - Stock Titan
Myomo Leads The Pack Of 3 Promising Penny Stocks - simplywall.st
Ascendiant Maintains Myomo(MYO.US) With Buy Rating, Raises Target Price to $10.5 - Moomoo
Myomo CMO Harry Kovelman sells $30,329 in stock By Investing.com - Investing.com Nigeria
Myomo CMO Harry Kovelman sells $30,329 in stock - Investing.com
Myomo (MYO) Latest: Moves 0.57% Lower to $1.73 on the Day; Technical View - vinanet.vn
Myomo (MYO) Q2 2026 Results: Profit Per Share Falls Below Its Benchmark for This Review; Market Reaction: The Stock Loses 0.57% for the Current SessionGross Profit Margin - vinanet.vn
Myomo chief medical officer sells $29,895 in shares - Investing.com India
Insider Selling: Myomo (NYSEAMERICAN:MYO) Insider Sells 17,250 Shares of Stock - MarketBeat
Myomo chief medical officer sells $29,895 in shares By Investing.com - Investing.com South Africa
Myomo (NYSE: MYO) officer eyes 17,500-share stock sale - Stock Titan
Rosalind Advisors, Inc. Expands Myomo Inc (MYO) Stake -- Shares Trade 48% Below GF Value - GuruFocus
Myomo (MYO) Shows Fast-paced Momentum But Is Still a Bargain Stock - qz.com
Myomo Inc. (MYO) Q2 2026 Earnings: EPS Misses Estimates as Loss Deepens, Shares Edge Up - Vinanet
Myomo (MYO): Rosalind Master Fund reports 9.18% stake and warrant blocker - Stock Titan
Q1 2026 Myomo Inc Earnings Call Transcript - GuruFocus
Q3 Earnings Estimate for Myomo Issued By HC Wainwright - MarketBeat
MYO Q2 2026 Earnings: EPS Miss of 18.8% Weighs on Shares as Loss DeepensProfit Recovery Report - dars.gov.et
Myomo Q2 Earnings Call Highlights - sharewise.com
A Quick Look at Today's Ratings for Myomo(MYO.US), With a Forecast Between $1.7 to $5 - Moomoo
Myomo revenue up 21% to USD 11.7M in Q2 2026 - Medical Buyer
Myomo earnings beat by $0.01, revenue topped estimates - Investing.com Nigeria
Craig-Hallum Maintains Myomo(MYO.US) With Buy Rating, Raises Target Price to $1.7 - Moomoo
Myomo Inc. (MYO) Surges 19% as Medical Robotics Stock Tests Key ResistanceOvervalued Signals - dars.gov.et
Myomo Inc (MYO) (Q2 2026) Earnings Call Highlights: Record Orders and Margin Expansion Drive Strong Quarter - GuruFocus
Myomo Inc (MYO) (Q2 2026) Earnings Call Highlights: Record Orders and Margin Expansion Drive ... - Yahoo Finance
Myomo Reports Second Quarter 2026 Financial and Operating Results - BioSpace
Earnings call transcript: Myomo tops Q2 2026 estimates and lifts revenue view - Investing.com
Is Myomo Inc (MYO) a Hidden Gem? Q2 Earnings Show Revenue of $11 - GuruFocus
Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Aug 05 (Reuters)Myomo Inc Q2 Operating Exp - Moomoo
MYOMO INC Q2 NET INCOME USD -1.2 MILLION - Moomoo
Q2 2026 Myomo Inc Earnings Call Transcript - GuruFocus
Press Release: Myomo Reports Second Quarter 2026 Financial and Operating Results - moomoo.com
Myomo(MYO) Stock Options Chain | Quotes & News - Moomoo
Myomo Q3 Results: Sales guidance beats analyst estimates - scanx.trade
MYO Q1 2026 Earnings: Loss Narrows to $0.05 Per Share, Beating Estimates by 56.6%New Analyst Coverage - dars.gov.et
Myomo Adds Seventh Director to its Board - mpo-mag.com
Myomo Inc (MYO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.26%
0.38%
자본화:
|
볼륨(24시간):